CT
IDXX icon

Clearstead Trust’s Idexx Laboratories IDXX Stock Holding History

Clearstead Trust’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$748K Sell
1,421
-65
-4% -$36.5K 0.1% 87
2026
Q1 		$835K Hold
1,486
– – 0.14% 84
2025
Q4 		$1.01M Sell
1,486
-29
-2% -$19.8K 0.16% 74
2025
Q3 		$968K Hold
1,515
– – 0.17% 73
2025
Q2 		$813K Buy
1,515
+16
+1% +$7.65K 0.15% 82
2025
Q1 		$630K Buy
1,499
+140
+10% +$60.8K 0.14% 86
2024
Q4 		$562K Sell
1,359
-81
-6% -$35.5K 0.12% 85
2024
Q3 		$728K Sell
1,440
-193
-12% -$93.8K 0.17% 70
2024
Q2 		$796K Sell
1,633
-30
-2% -$15.1K 0.2% 63
2024
Q1 		$898K Hold
1,663
– – 0.23% 60
2023
Q4 		$923K Hold
1,663
– – 0.25% 60
2023
Q3 		$727K Buy
1,663
+235
+16% +$117K 0.24% 64
2023
Q2 		$717K Sell
1,428
-52
-4% -$24.9K 0.23% 71
2023
Q1 		$740K Sell
1,480
-305
-17% -$146K 0.24% 71
2022
Q4 		$728K Hold
1,785
– – 0.24% 64
2022
Q3 		$582K Buy
1,785
+1,500
+526% +$551K 0.2% 67
2022
Q2 		$100K Hold
285
– – 0.08% 102
2022
Q1 		$156K Sell
285
-2
-0.7% -$1.05K 0.1% 97
2021
Q4 		$189K Hold
287
– – 0.11% 92
2021
Q3 		$178K Hold
287
– – 0.11% 94
2021
Q2 		$181K Buy
+287
New +$158K 0.12% 93
2021
Q1 		– Sell
-287
Closed -$143K – 134
2020
Q4 		$143K Hold
287
– – 0.09% 106
2020
Q3 		$113K Hold
287
– – 0.09% 100
2020
Q2 		$95K Sell
287
-2
-0.7% -$579 0.08% 103
2020
Q1 		$70K Hold
289
– – 0.06% 114
2019
Q4 		$75K Hold
289
– – 0.05% 121
2019
Q3 		$79K Sell
289
-11
-4% -$3.06K 0.06% 118
2019
Q2 		$83K Hold
300
– – 0.07% 116
2019
Q1 		$68K Hold
300
– – 0.06% 123
2018
Q4 		$56K Buy
+300
New +$61.5K 0.05% 138

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Clearstead Trust's IDXX Position: Q2 2026 in Review

Clearstead Trust reduced its Idexx Laboratories (IDXX) stake by 4.4% in Q2 2026, selling an estimated $36.5K and leaving 1,421 shares worth $748K. The position accounts for 0.1% of the portfolio, ranked #87.

Clearstead Trust first reported a position in IDXX in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.01M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Clearstead Trust held 1,421 shares of Idexx Laboratories worth $748K as of Q2 2026.
  • Clearstead Trust sold 65 Idexx Laboratories shares in Q2 2026, an estimated $36.5K.
  • Idexx Laboratories made up 0.1% of Clearstead Trust's portfolio in Q2 2026, its #87 holding.
  • Clearstead Trust first reported a position in Idexx Laboratories in Q4 2018 and has held it in 30 quarters since.
  • Clearstead Trust's Idexx Laboratories position peaked at $1.01M in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.